Join to View Full Profile
1830 East Shepherd AvenueDept. Of Pediatric Neuro-OncologyFresno, CA 93720
Phone+1 646-591-1563
Dr. Samuel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- David Samuel, MD, is a Board Certified Pediatric Hematologist/Oncologist based in Fresno, CA, and served as a Pediatric Neuro-Oncologist at the Valley Children's Hospital in Madera, CA from January 2010 to August 2023. He completed his medical education at the University of Dundee, Scotland followed by Pediatric Residencies at the Children's Hospital Los Angeles and University of California, Irvine. He further specialized with a Fellowship in Pediatric Hematology/Oncology at the National Cancer Institute. After working as a Locum Consultant in the UK, Dr. Samuel returned to the US to complete two years in Pediatric Neuro-Oncology Fellowships at the Memorial Sloan-Kettering Cancer Center and the Dana-Farber Cancer Institute in Boston. Dr. Samuel has contributed to several publications in his field, with a focus of using molecular profiling to assist in the management of a broad range of pediatric Central Nervous System and Spinal tumors.
Education & Training
National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 1995 - 1999
Children's Hospital Los AngelesResidency, Pediatrics, 1994 - 1995
University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 1992 - 1994
Univ Dundee- Fac MedClass of 1989
Certifications & Licensure
CA State Medical License 1993 - 2025
MA State Medical License 2008 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Comparative Clinical and Imaging-Based Evaluation of Therapeutic Modalities in CNS Embryonal Tumours With PLAGL Amplification.Michaela-Kristina Keck, Anna Tietze, Brigitte Bison, Shivaram Avula, Julien Engelhardt
Neuropathology and Applied Neurobiology. 2025-04-01 - 2 citationsGermline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.Svenja Kastellan, Reinhard Kalb, Bia Sajjad, Lisa J McReynolds, Neelam Giri
Journal of Hematology & Oncology. 2024-04-29 - 8 citationsCombined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Con...Anirban Das, Nicholas R Fernandez, Adrian Levine, Vanessa Bianchi, Lucie K Stengs
Cancer Discovery. 2024-02-08
Journal Articles
- The Genetic Landscape of Gliomas Arising After Therapeutic RadiationIwei Yeh, Corey Raffel, Mitchel Berger, Joanna J Phillips, James P Grenert, Boris C Bastian, David A Solomon, Nicholas Butowski, Sabine Mueller, Cassie Kline, Manish A..., Acta Neuropathologica
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
